Rosalynn is an experienced executive scientist, who has worked in start-up and early stage biotech companies, with a focus on genomics and molecular diagnostics. Rosalynn is known as an innovative problem solver, has successfully raised over 30 million dollars in venture capital and institutional funding, is experienced in managing global multi-disciplinary teams, is well-versed in federal, state and European regulatory affairs, and has considerable international communication and media experience.
LinkedIn with Rosalynn www.linkedin.com/pub/rosalynn-gill/1/1b9/490
Newsletter